Exploring Intratumoral Heterogeneity of Lipid Metabolism in Clear Cell Renal Cell Carcinoma with Dixon-based MRI
Yue Zhang1, Payal Kapur2,3,4, Jin Ye5, Qing Yuan1, Ananth Madhuranthakam1,6, Ivan Dimitrov7, Yin Xi1, Takeshi Yokoo1,6, Jeffrey Cadeddu1,3, Vitaly Margulis3, Andrea Pavía-Jiménez4,8, James Brugarolas4,8,9, Robert E. Lenkinski1,6, and Ivan Pedrosa1,4,6

1Radiology, UT Southwestern Medical Center, Dallas, TX, United States, 2Pathology, UT Southwestern Medical Center, Dallas, TX, United States, 3Urology, UT Southwestern Medical Center, Dallas, TX, United States, 4Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, United States, 5Molecular Genetics, UT Southwestern Medical Center, Dallas, TX, United States, 6Advanced Imaging Research Center, UT Southwestern Medical Center, Dallas, TX, United States, 7Philips Medical Systems, Cleveland, OH, United States, 8Internal Medicine, UT Southwestern Medical Center, Dallas, TX, United States, 9Developmental Biology, UT Southwestern Medical Center, Dallas, TX, United States

Synopsis

We investigated the correlation between in vivo fat fraction (FF) measurements by Dixon-based MRI in clear cell renal cell carcinoma (ccRCC) and both intracellular fat accumulation at histopathology and lipidomic profile in the same tumor by mass spectrometry. Quantitative targeted fat fraction measures were obtained from representative areas within each tumor and correlated with the percentage of cells containing fat in fresh tissue samples from the same location of the tumor. Lipidomic analysis of additional tissue samples was performed. Quantitative FF measures correlated with lipid accumulation in ccRCC and provide a tool for assessing heterogeneous metabolic pathways in these tumors.

INTRODUCTION

The Tumor Cancer Genome Atlas (TCGA) analysis of gene and protein expression has confirmed major alterations in glucose, amino acid and lipid metabolism in clear cell renal cell carcinoma (ccRCC), the most common type of RCC, which is characterized by histologically prominent storage of glycogen and lipids (1). ccRCC expresses high levels of enzymes necessary to produce fatty acids and other lipids, and two of these, fatty acid synthase (FAS) and stearoyl-CoA desaturase (SCD1), are associated with poor prognosis (2,3). These observations strongly suggest that reprogrammed lipid metabolism in ccRCC might provide not only biomarkers of oncological aggression, but perhaps therapeutic targets as well. Thus, exploring non-invasive MRI methods as predictive metabolic biomarkers in ccRCC is appealing. However, ccRCC is characterized by intratumoral molecular heterogeneity (4), which likely drives the biological behavior of this disease. Moreover, to our knowledge, the heterogeneity of lipid accumulation in ccRCC has not been previously studied. The purpose of this study was to assess intratumoral heterogeneity of lipid accumulation in ccRCC in vivo and to correlate MRI-based fat fraction measures with lipid accumulation at histopathology and the lipidomic profile in the same tumor.

MATERIALS AND METHODS

Patients and MRI Protocol: This was a prospective, IRB-approved, HIPAA-compliant study. 36 patients with pathologically confirmed ccRCC (after nephrectomy) signed informed consent and underwent 3T dual-transmit MRI with a 16-channel SENSE-XL-Torso coil (n=23, Achieva; n=13, Ingenia, Philips Healthcare, Best, the Netherlands). Axial and coronal T2-weighted single-shot turbo spin-echo images (T2WI) were acquired to localize the tumor followed by axial breath-held three-dimensional (3D) T1-weighted (T1W) fast field-echo (FFE) multi-echo DIXON (mDIXON)(TR/TE = 6.7~8/1.09~1.24 ms, ΔTE = 0.9~1.1ms, 6 echoes, FA = 2~3°, NSA = 1, thickness = 3mm, in-plane resolution = 1.5mm×2mm, acquisition FOV = 402×240×96 mm2, acquisition matrix = 268×120×32, bandwidth = 1413.2 Hz/pixel, acquisition time= 15~19 seconds). Image Analysis: Fat fraction (FF) maps were reconstructed based on a 7-peak spectral modeling (5). Using a DICOM viewer (OsiriX), up to 8 (4 for small lesions) random regions of interest (rROIs) were placed within each tumor on the FF map to assess tumor heterogeneity; half in a superior slice and the other half in an inferior slice through the mass. In addition, targeted ROIs (tROIs) were placed on representative locations of the tumor including an area with high lipid content (when present) on the FF map. Histopathology: After partial (n=23), radical (n=12) or simple (n=1) nephrectomy, tumor specimens were anatomically oriented with the use of fiducial markers placed during surgery and then bivalded through the center to match the location of the MRI acquisitions. Tumor slides were obtained from the selected cutting location and stained with hematoxylin-eosin for assessment of nuclear (Fuhrman) tumor grade. A total of 17 fresh tumor samples matching the location of at least one tROI were obtained from 14 patients (2 samples from one patient, 3 samples from one patient) and stained with Oil Red O. The percentage of cells that stained with Oil Red O was estimated visually to the nearest percentage by a uropathologist who was blinded to the FF results. Additional fresh tissue samples matching tROIs were used for lipidomic analysis with gas chromatography-electron capture negative ionization-mass spectrometry. Statistics: Mean FF and standard deviation (SD) for rROIs were correlated to tumor grade. Spearman correlation and linear regression model were used to assess the relationship between FF, Oil Red O percentage and lipidomic results (P<0.05 considered statistically significant).

RESULTS

Fig.1 shows representative images of one tumor and placement of 8 rROIs. We found heterogeneous lipid accumulation both among different tumor grades and within each tumor (Fig.2). Levels of lipid accumulation and heterogeneity (SD) were not correlated with tumor grade or size (P>0.05). FF measures in tROIs correlated statistically with Oil Red O percentage (ρ=0.90, P<0.0001) (Fig.3). Fig. 4 shows representative images in a tumor with low fat content and a tumor with high fat content, tROI in each tumor, and correlative Oil Red O stain in the same location of the tumor. FF measures correlated positively with increased triglycerides (TG) (P=0.0007) and free cholesterol (P=0.006) counts in lipidomic analysis of fresh tissue samples in the same location of the tumor.

DISCUSION

Dixon-based MRI offers an opportunity to characterize renal tumors in vivo based on lipid accumulation. Furthermore, Dixon-based MRI-directed targeted tissue sampling provides a platform for understanding intratumoral heterogeneity in lipid metabolism that may be leveraged to identify potential therapeutic targets.

CONCLUSION

Quantitative Dixon-based MRI allows for noninvasive assessment of intratumoral heterogeneity of lipid metabolism in ccRCC.

Acknowledgements

Supported by Grant NIH/NCI 1R01CA154475.

References

1. http://cancergenome.nih.gov/cancersselected/kidneyclearcell

2. Horiguchi A, Asano T, Asano T, et al. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol. 2008 Sep;180(3):1137-40.

3. von Roemeling CA, Marlow LA, Wei JJ, et al. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 2013 May 1;19(9):2368-80.

4. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366:883–892.

5. Ren J, Dimitrov I, Sherry D, et al. Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. Journal of Lipid Research, 2008, 49: 2055-2062.

Figures

Fig.1: Coronal (left) and axial (middle) T2WI images in high-grade (Fuhrman 3) ccRCC. Eight ROIs were placed, 4 in the superior slice (green outline) and 4 in the inferior slice (purple outline). % FF for each ROI is shown in FF maps (right). Mean FF and SD was 11.0% ± 5.0%.

Fig.2: Mean fat fraction (FF) by Dixon MRI in each ccRCC across 36 patients. Data indicate marked heterogeneity in the amount of lipids among grade 2 (G2) and 3 (G3) tumors. Note also marked intratumoral heterogeneity illustrated by the large standard deviation of multiple measures in the same tumor (whiskers).

Fig.3: Fat fraction (FF) on Dixon MRI correlates to Oil Red O percentage at histopathology (Spearman ρ=0.90, P<0.0001; linear regression Y = 0.13*X, P<0.0001). Each dot indicates results of a targeted ROI within a tumor and corresponding fresh tissue assessment obtained in the same location.

Fig.4: Targeted fat fraction (orange circle) levels correspond to intracellular lipid at histopathology. Tumor 1: A FF of 1.93% corresponds to 5% of cells staining positively (arrows) on Oil Red O. Tumor 2: A FF of 13.99% corresponds to 90% of cells staining positively on Oil Red O.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
3907